Date published: 2026-2-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

HSV-1 Antibody (202): sc-57864

2.0(1)
Write a reviewAsk a question

Datasheets
  • HSV-1 Antibody (202) is a mouse monoclonal IgG2a provided at 100 µl ascites
  • raised against HSV-1 and -2 infected cells
  • recommended for detection of herpes simplex virus 1 by IF
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for HSV-1 Antibody (202). This work is in progress.
    Crispr Promo Banner

    QUICK LINKS

    SEE ALSO...

    HSV-1 Antibody (202) is a mouse monoclonal IgG2a antibody that detects herpes simplex virus 1 protein through immunofluorescence (IF). Anti-HSV-1 antibody (202) is available in non-conjugated form, providing researchers with a reliable tool for studying this viral pathogen. HSV-1 (202) monoclonal antibody shows non-species reactivity. The herpes simplex virus (HSV), commonly associated with cold sores and fever blisters, primarily affects the orofacial region. HSV-1 establishes latency within sensory neurons after initial infection, enabling viral evasion of host immune response and leading to potential reactivation and recurrent outbreaks. Understanding latency and reactivation mechanisms is vital for developing effective therapeutic strategies and vaccines against HSV-1, as recurrent infections impact quality of life for affected individuals. Anti-HSV-1 antibody (202) serves as an essential tool for researchers investigating herpes simplex virus biology and host cell interactions.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    HSV-1 Antibody (202) References:

    1. HSV-1 Amplicon Vectors as Genetic Vaccines.  |  Meier, AF. and Laimbacher, AS. 2020. Methods Mol Biol. 2060: 111-130. PMID: 31617175
    2. Negative epidemiological association between HSV-1 and HSV-2 infections.  |  Nasrallah, GK., et al. 2019. Heliyon. 5: e02549. PMID: 31687480
    3. The HSV-1 ubiquitin ligase ICP0: Modifying the cellular proteome to promote infection.  |  Rodríguez, MC., et al. 2020. Virus Res. 285: 198015. PMID: 32416261
    4. HSV-1 Infection: Role of Viral Proteins and Cellular Receptors.  |  Amin, I., et al. 2019. Crit Rev Eukaryot Gene Expr. 29: 461-469. PMID: 32422002
    5. HSV-1 Infection Induces a Downstream Shift of Promoter-Proximal Pausing for Host Genes.  |  Weiß, E., et al. 2023. J Virol. 97: e0038123. PMID: 37093003
    6. Outcomes of HSV-1 encephalitis infection in glioblastoma: An integrated systematic analysis.  |  Mendez Valdez, MJ., et al. 2023. Microb Pathog. 181: 106211. PMID: 37343897
    7. HSV-1 selectively packs the transcription factor Oct-1 into EVs to facilitate its infection.  |  Ma, Y., et al. 2023. Front Microbiol. 14: 1205906. PMID: 37396389
    8. OPTN-TBK1 axis and a role for PLK1 in HSV-1 infection.  |  Bhattacharya, I., et al. 2023. mBio. 14: e0271523. PMID: 38019030
    9. HSV-1 infection induces phosphorylated tau propagation among neurons via extracellular vesicles.  |  Protto, V., et al. 2024. mBio. 15: e0152224. PMID: 39189744
    10. Vistas in Signaling Pathways Implicated in HSV-1 Reactivation.  |  Papavassiliou, KA., et al. 2024. Int J Mol Sci. 25: PMID: 39596536

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    HSV-1 Antibody (202)

    sc-57864
    100 µl ascites
    $322.00